The forward P/E of 40.3x implies the market expects earnings to grow roughly 46% over the next year, aligning with the 36% revenue growth reported in Q2 2026. However, the PEG of 1.65 suggests that the growth is not fully rewarded, likely due to the perceived geopolitical overhang. Compared to Camtek's 159x P/E and Onto's 119x, ACMR appears cheaper on a growth-adjusted basis, but the discount may reflect the higher risk of export controls disrupting its China-centric revenue base. Investors should monitor whether the valuation re-rates as diversification into ECP and advanced packaging reduces concentration risk.

The gross margin decline is consistent with the mix shift toward lower-margin ECP and furnace tools, which grew 168% and 153% respectively, but the operating margin improvement indicates that revenue growth is outpacing fixed cost increases. The net margin of 30.4% is unsustainable as it likely includes a tax benefit; normalizing for this, net margin would be closer to 15%, still above the 13.8% reported in Q2 2025. This suggests that core profitability is improving, but investors should adjust for non-recurring items to gauge true earning power.

The low ROIC of 2.3% is partly due to the massive cash pile of $990.6 million, which earns minimal returns, and the heavy investment in working capital and PPE. While the company is growing rapidly, the return on invested capital is not yet reflecting the scale benefits, as asset turnover is only 0.09x. This suggests that the company is in a heavy investment phase, and investors should expect ROIC to improve as revenue scales and working capital normalizes. The 93% increase in equity, driven by retained earnings, has not yet translated into proportional returns.

The CCC of 480 days is a red flag, as it indicates that cash is tied up in receivables and inventory for over a year. DSO of 184 days suggests that customers, likely Chinese fabs, are taking extended payment terms, possibly due to financing constraints. DIO of 437 days reflects the buildup of inventory to support rapid growth and potential supply chain disruptions. While the company has a fortress balance sheet to absorb this, the negative FCF margin of -24.4% in Q2 2026 highlights the risk that growth is consuming cash faster than it generates it. Investors should monitor whether the company can tighten credit terms and reduce inventory as it matures.

The low D/E ratio of 0.15 and high interest coverage of 66.9x suggest that debt service is not a concern. However, the absolute debt level has risen, and D/EBITDA has increased from 3.80 to 5.68 over the past year, indicating that EBITDA growth has not kept pace with debt accumulation. This is likely due to the company borrowing to fund its expansion, but the fortress cash position of $990.6 million provides a significant buffer. The risk is not insolvency but rather the opportunity cost of holding low-yielding cash while borrowing, which could weigh on returns.

The current ratio of 3.66 and quick ratio of 2.66 suggest that ACMR can easily meet its short-term liabilities, even if inventory becomes difficult to liquidate. The high cash balance, much of which is held at the subsidiary level in China, may not be fully accessible for US-based capital returns, but it does provide a cushion against operational disruptions. Under a severe stress scenario, such as a sudden halt in shipments due to export controls, the company could likely sustain operations for several quarters without external financing. However, the negative operating cash flow in Q2 2026 indicates that the liquidity buffer is being tested by working capital needs.